Literature DB >> 34604198

Successful Treatment of Late Isolated Bone Metastasis in a Patient with Bilateral Retinoblastoma Using an Unconventional Method.

Deepthi Boddu1, Priyakumari Thankamony1, Reshma Prakasam2, Subin Sugath3, Aswin Kumar4, Sindhu Nair5.   

Abstract

Though survival in bilateral retinoblastoma (RB) has improved due to advancement in diagnostics and treatment modalities, children require long-term follow-ups for recurrence and second malignancies. We report a case of bilateral RB in a 7-month-old baby who was treated with chemotherapy, transpupillary thermotherapy, and periocular carboplatin for both eyes following which there was complete regression of tumour. Six and a half years after treatment, the child presented with metastatic recurrence of tumour in the left ulna. He was treated successfully with chemotherapy, extracorporeal radiation and reimplantation therapy. A less aggressive treatment approach for isolated bone relapse may be considered in selected cases.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  ECRT; Late metastasis; Relapse; Retinoblastoma

Year:  2021        PMID: 34604198      PMCID: PMC8443926          DOI: 10.1159/000514620

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  16 in total

1.  Successful Treatment of Relapsed Isolated Extraocular Retinoblastoma in the Right Fibula With High-dose Chemotherapy and Autologous Stem Cell Transplantation.

Authors:  Ramya Uppuluri; Dhaarani Jayaraman; Meena Sivasankaran; Shivani Patel; Venkateswaran Vellaichamy Swaminathan; Revathi Raj
Journal:  J Pediatr Hematol Oncol       Date:  2019-07       Impact factor: 1.289

2.  Clinical presentation and survival of retinoblastoma in Indian children.

Authors:  Bhavna Chawla; Fahmi Hasan; Rajvardhan Azad; Rachna Seth; Ashish Datt Upadhyay; Sushmita Pathy; R M Pandey
Journal:  Br J Ophthalmol       Date:  2015-06-10       Impact factor: 4.638

3.  Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.

Authors:  Danielle Novetsky Friedman; Joanne F Chou; Kevin C Oeffinger; Ruth A Kleinerman; Jennifer S Ford; Charles A Sklar; Yuelin Li; Mary S McCabe; Leslie L Robison; Brian P Marr; David H Abramson; Ira J Dunkel
Journal:  Cancer       Date:  2016-01-11       Impact factor: 6.860

4.  Very late relapse of bilateral retinoblastoma.

Authors:  Jung Yoon Choi; Hyoung Jin Kang; Ji Won Lee; Hee Young Ju; Che Ry Hong; Hyery Kim; Young Suk Yu; Sung-Hye Park; Jung-Eun Cheon; Kyung Duk Park; Hee Young Shin
Journal:  J Pediatr Hematol Oncol       Date:  2015-05       Impact factor: 1.289

5.  Metastatic retinoblastoma. Recent progress of interest to orthopaedic surgeons.

Authors:  J E Blank; J P Dormans; B P Himelstein; D Yamashiro
Journal:  Clin Orthop Relat Res       Date:  1995-06       Impact factor: 4.176

6.  Bilateral retinoblastoma presenting as metastases to forearm bones four years after the initial treatment.

Authors:  Manohar Kuruva; Bhagwant Rai Mittal; Raghava Kashyap; Anish Bhattacharya; Ram Kumar Marwaha
Journal:  Indian J Nucl Med       Date:  2011-04

Review 7.  Adult onset retinoblastoma.

Authors:  Sabyasachi Sengupta; Utsab Pan; Vikas Khetan
Journal:  Indian J Ophthalmol       Date:  2016-07       Impact factor: 1.848

8.  Long-term follow-up of retinoblastoma survivors: Experience from India.

Authors:  Rachna Seth; Amitabh Singh; Vijay Guru; Bhavna Chawla; Sushmita Pathy; Savita Sapra
Journal:  South Asian J Cancer       Date:  2017 Oct-Dec

9.  Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.

Authors:  Jasmine H Francis; Ariana M Levin; Emily C Zabor; Y Pierre Gobin; David H Abramson
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

10.  Bone metastasis of retinoblastoma five years after primary treatment.

Authors:  Saskia C Ting; Tobias Kiefer; Karoline Ehlert; Sophia L Goericke; Raoul Hinze; Petra Ketteler; Nikolaos E Bechrakis; Hans-Ulrich Schildhaus
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.